近五年第一或通讯作者发表论文:(*表示通讯作者)
(1) Chen, Y., Qin, Y., Dai, M.M., Liu, L.P., Ni, Y., Sun, Q.S., Li, L.L., Zhou, Y.Y., Qiu, C., and Jiang, Y.Y.* (2021). IBSP, a potential recurrence biomarker, promotes the progression of colorectal cancer via Fyn/beta-catenin signaling pathway. Cancer Medicine 10, 4030-4045.
(2) Yan Chen, Danqi Chen, Ying Qin, Yaoyao Zhou, Cheng Qiu, Mengmeng Dai, Lulu Li, Yuyang Jiang*. TRIP13, identified as a hub gene of tumor progression, is the target of microRNA-4693-5p and as a potential therapeutic target for colorectal cancer. Cell Death Discovery. Cell Death Discov. 2022 Jan 24;8(1):35.
(3) Chen, D.Q., Qin, Y., Dai, M.M., Li, L.L., Liu, H.P., Zhou, Y.Y., Qiu, C., Chen, Y.*, Jiang, Y.Y.* (2020). BGN and COL11A1 Regulatory Network Analysis in Colorectal Cancer (CRC) Reveals That BGN Influences CRC Cell Biological Functions and Interacts with miR-6828-5p. Cancer Manag Res 12, 13051-13069.
(4) Haoting Zheng, Qiuzi Dai, Zigao Yuan, Tingting Fan, Cunlong Zhang, Zijian Liu, Bizhu Chu, Qinsheng Sun, Yan Chen*, Yuyang Jiang*. Quinazoline-based hydroxamic acid derivatives as dual histone methylation and deacetylation inhibitors for potential anticancer agents. Bioorg Med Chem. 2022 Jan 1;53:116524.
(5) Lizhen Ye, Tingting Fan, Ying Qin, Cheng Qiu, Lulu Li, Mengmeng Dai, Yaoyao Zhou, Yan Chen* ,Yuyang Jiang*.MicroRNA-455-3p Accelerate Malignant Progression of Tumor by Targeting H2AFZ in Colorectal Cancer. CELL CYCLE, 2022, Accepted.
用户登录
还没有账号?
立即注册